Navigation Links
Neuralstem ALS Trial Data Presented At The American Association Of Neurological Surgeons Annual Meeting
Date:4/29/2013

dy author. "These patients are in many ways more fragile, and at greater risk from spinal surgery, than patients with other types of diseases or injuries where our cell therapy may be applicable. That our cells and method of delivery are safe in ALS patients bodes very well for expanding to other indications. We expect to commence our FDA-approved Phase I trial in chronic spinal cord injury later this year using the same methodology. We want to thank the surgeons at Emory, who developed these techniques, as well as the patients and their families who have taken part in the trial."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem completed an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig 's disease, in February 2013, and has received FDA approval to begin Phase II. Neuralstem has been awarded orphan status designation by the FDA for its ALS cell therapy.

In addition to ALS, the company is also targeting major central nervous system conditions with its NSI-566 cell therapy platform, including spinal cord injury, ischemic stroke and glioblastoma (brain cancer). The company received approval to commence a Phase I safety trial in chronic spinal cord injury in January 2013.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  The company is in the las
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
2. Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel At BIO International Convention
3. Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
4. Neuralstem Secures $8 Million In Debt Financing From Hercules
5. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
6. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
7. Neuralstem to Raise $7.0 Million in Registered Direct Offering
8. Neuralstem Announces Proposed Public Offering
9. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
10. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
11. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 The American Association for ... Design and Manufacturing has joined the AAHomecare Corporate Partner ... Harvey Diamond have been actively involved in AAHomecare ... it has quickly grown into a major global manufacturer ... Drive allows AAHomecare to increase efforts on behalf of ...
(Date:9/19/2014)... Larry J. Merlo , President and CEO ... before the National Press Club in Washington, D.C. ... to stop selling tobacco products and its leadership in driving ... "Dramatic changes in our health care system pose enormous ... has said. "CVS Health has a truly unique combination of ...
(Date:9/19/2014)... Sept. 19, 2014  Lpath, Inc. (NASDAQ: ... lipid-targeted therapeutics, announced today that it has entered ... of common stock and 3,605,042 unregistered warrants in ... for one registered share of common stock and ... of common stock will be $3.475.  The warrants ...
Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... Endosurgery, Inc. announced that their newly-launched OverStitch™ Endoscopic ... first-in-human cases. OverStitch ... mimics the way physicians deploy sutures by hand.  It ... surgical standard of care through the flexible endoscope.   ...
... Oct. 28 The U.S. Food and Drug ... the treatment of adults with schizophrenia. ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) Schizophrenia affects ... 18 years and older, in a given year. ...
Cached Medicine Technology:Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System 2FDA Approves Latuda to Treat Schizophrenia in Adults 2
(Date:9/19/2014)... 2014 Lipitor lawsuits ( http://www.thelipitorlawsuit.com/ ... to develop Type 2 diabetes continue to move forward ... District Court, District of South Carolina, Bernstein Liebhard LLP ... 12, 2014, discovery is underway and moving forward in ... Pfizer, Inc., the manufacturer of Lipitor, has produced millions ...
(Date:9/19/2014)... 2014 MetroMD, a leading anti-ageing clinic has ... of human health. This therapy has grown tremendously across USA ... more effective, safe and dependable. It has far reaching benefits ... to live a very healthy and active lifestyle even beyond ... therapy, a senior therapist at MetroMD said, “HGH or Human ...
(Date:9/19/2014)... Cellular therapeutics using intact cells to treat and ... in medicine but it is hindered by the inability ... destination and persistence of these cells in patients without ... a paper published September 17 in the online journal ... University of California, San Diego School of Medicine, University ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 "I ... fear getting wrinkles due to stretching the skin around ... Anniston, Ala. "This inspired me to design a more ... EYE CONTACT LENS SYSTEM provides a quicker, easier, more ... the need to perform this task manually, saves time ...
(Date:9/19/2014)... 2014 In partnership with Raw Beauty NYC, ... part of the project’s social media efforts. StudioPMG is honored ... re-define the perception of beauty as it applies to disabled ... idea by Shelly Baer and Vanessa Silberman, who wanted to ... and beautiful. Ginny Dixon, Wendy Crawford, Susan Solman and Sabrina ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:A better way to track emerging cell therapies using MRIs 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2
... 31 On April 1, the federal cigarette tax will ... pack, to fund the expansion of the State Children,s Health ... A new survey shows that the April 1st federal ... concerns for smokers and will change their current smoking habits.(2)The ...
... Health today announced that its Clinical and Medical ... off later this year as CareFusion Corporation, will ... six months and eliminate an additional 500 positions ... addition, Cardinal Health will implement cost control measures ...
... Scientific Company (ESC) is demonstrating a critical technology ... which link healthcare enterprises into the Nationwide Health ... Management Systems Society (HIMSS) conference, April 5-8, 2009. ... problem healthcare enterprises face in providing interoperable, authorized ...
... testimony today before the U.S. Senate Committee on Agriculture, ... revise school food nutrition standards so that more nutritious ... federal nutrition standards for foods sold outside of the ... updated since the late 1970s. , ...
... Infusing cells into damaged area helped restore blood flow, ... Treating a heart attack with the patients, own bone ... and may help reduce long-term complications, a new U.S. ... underwent angioplasty and stent placement after a heart attack. ...
... for dieters who face food challenges in the break room every ... shows that our resistance gets a boost after we,ve just ... a real one for many of us. It is all too ... with their desire to smoke or to drink alcohol or to ...
Cached Medicine News:Health News:Federal Cigarette Tax Increase and Current Economy Will Change Smoker's Habits 2Health News:Federal Cigarette Tax Increase and Current Economy Will Change Smoker's Habits 3Health News:Federal Cigarette Tax Increase and Current Economy Will Change Smoker's Habits 4Health News:Cardinal Health to Reduce Workforce to Respond to Economic Conditions 2Health News:Cardinal Health to Reduce Workforce to Respond to Economic Conditions 3Health News:Edmond Scientific Company Demonstrates RHIO/HIE Data Security and Privacy Solution for the NHIN at Annual HIMSS Conference, Chicago '09 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 3Health News:Patient's Own Stem Cells Might Treat Heart Attack 2Health News:Learning curve: Tricks to resist temptation 2
Disposable Microscissors: Horizontal, Curved...
Sharp tipped scissors with a vertical cutting action. Rounded lower edge of scissors blade minimizes unintentional engagement of retina....
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
Sharp tipped scissors with a curvature of 12 mm to follow the contour of the retina. For cutting in the plane parallel to the retina, cutting membranes adherent to the retinal surface and all purpose...
Medicine Products: